About Careers Internship MedBlog Contact us

Implementation of HPV Vaccinations At A Young Age Is Important For Its Effectiveness: Study

by Rukmani Krishna on March 14, 2013 at 11:14 PM
Font : A-A+

 Implementation of HPV Vaccinations At A Young Age Is Important For Its Effectiveness: Study

According to a Swedish study initial vaccinations for human papillomavirus (HPV) at a young age is important for maximizing quadrivalent HPV vaccine effectiveness. The study was published on March 13 in the Journal of the National Cancer Institute.

HPV vaccination programs have been launched around the world in hopes of preventing cervical cancer and other HPV-related cancers. While incidence of genital warts is the earliest possible disease outcome to measure the efficacy of the HPV vaccine, the results of such efficacy trials may not be fully generalizable to real-life HPV vaccination programs. Furthermore, incidence of genital warts after on-demand vaccination with quadrivalent HPV vaccine using individual-level data remains unknown.


In order to determine the efficacy of maximizing HPV vaccines at a young age, Amy Leval, R.N., of the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet in Stockholm, Sweden and colleagues, looked at a cohort of females ages 10 to 44 years living in Sweden between 2006-2010 who were linked to multiple population registers to identify genital warts incidence in relation to HPV vaccination. Incidence rate ratios of genital warts were estimated using time-to-event analyses with adjustment for attained age and parental education level, stratified by age at first vaccination.

The researchers found that of the cohort, females with at least one university-educated parent were 15 times more likely to be vaccinated for HPV before age 20 years than females whose parents had not completed high school. For females over the age of 20, the rates of genital warts incidence decreased among the unvaccinated, suggesting that women with a high risk of genital warts favorably used HPV vaccines. The authors note their limitations, however, saying, "Interpreting the crude estimates of effectiveness for those aged 20 years or older at first vaccination is difficult because we found evidence suggesting a self-selection bias with women at high risk preferentially seeking vaccination."

In an accompanying editorial, Jennifer S. Smith, Ph.D., M.P.H., of the Gillings School of Global Public Health, University of North Carolina, and Elisabete Weiderpass, Ph.D., of Karolinska Institutet, write that the low HPV vaccination coverage before the national school-based program in Sweden was implemented gave the opportunity to compare the incidence of genital warts in vaccinated cohorts with that in unvaccinated cohorts. "Future studies in Sweden—and elsewhere where HPV vaccine coverage rates are high in target populations, such as Australia and Canada—may need to compare vaccinated birth cohorts with older birth cohorts that were previously unvaccinated to evaluate the impact of vaccination on the population level."

Source: Eurekalert


Recommended Readings

Latest General Health News

What Are the Consequences of Celebrities Endorsing Tobacco?
In India, youth must be aware of the diseases linked to cigarette smoking and tobacco consumption, causing a form of healthcare emergency.
 People Living Close to the Seaside Enjoy Better Health
Direct coastal access may represent a viable route to public health promotion, but the relationships of coastal living are not strongest among lower-income groups.
 Over Four Million Gardeners Place Their Hearing in Danger
New research by Tinnitus UK has found that over four million gardeners are putting their hearing capacity at risk this summer without using safety protection.
Breaking the Barrier: Unraveling Mucus Plugs to Save Lives in COPD
Mucus plugs could be targeted to help reduce fatalities from chronic obstructive pulmonary disease.
 Disease Modifying Therapies for Multiple Sclerosis Continue to Drive Up Healthcare Cost
The development of reliable curative therapies for multiple sclerosis could significantly reduce the economic burden of the disease on patients and wider society.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Implementation of HPV Vaccinations At A Young Age Is Important For Its Effectiveness: Study Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests